AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15504189 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg
Number of subjects: 10
Study 15504189 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 2 ml (placebo)
Number of subjects: 10
Study 11072160 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine during radiation therapy (RT)
Number of subjects: 303
Study 11072160 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-amifostine treated patients)
Number of subjects: 303
Study 9255079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin and metronidazole
Number of subjects: 112
Study 9255079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 8438744 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (n = 71)
Number of subjects: 191
Study 8438744 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (n = 51)
Number of subjects: 191
Study 8438744 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (n = 23)
Number of subjects: 191
Study 8438744 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (n = 18)
Number of subjects: 191
Study 3324039 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional steroid injection (2.5 mg) and griseofulvin
Number of subjects: 30
Study 3324039 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin only
Number of subjects: 30
Study 30945920 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional Work (TW)
Number of subjects: 270
Study 30945920 — intervention group
Group type: COMPARATOR
Intervention: Nonengagers (Control)
Number of subjects: 270
Study 29589786 — intervention group
Group type: EXPERIMENTAL
Intervention: Exeter polished tapered stem and Unitrax modular head
Number of subjects: 964
Study 29589786 — intervention group
Group type: COMPARATOR
Intervention: Thompson hemiarthroplasty
Number of subjects: 964
Study 26839075 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum R0071
Number of subjects: 581
Study 26839075 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum ssp. infantis R0033
Number of subjects: 581
Study 26839075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 581
Study 24804698 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 64942
Study 24804698 — intervention group
Group type: COMPARATOR
Intervention: No diabetes (Control)
Number of subjects: 64942
Study 22840687 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported assessment of care from any healthcare source (CDM clinic or elsewhere)
Number of subjects: 0
Study 22840687 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported measure of care at a CDM clinic
Number of subjects: 0
Study 22840687 — intervention group
Group type: COMPARATOR
Intervention: Visit frequency based measure
Number of subjects: 0
Study 19822721 — intervention group
Group type: EXPERIMENTAL
Intervention: BLETRAC (Bilateral Leg Training with Rhythmic Auditory Cueing)
Number of subjects: 24
Study 19822721 — intervention group
Group type: COMPARATOR
Intervention: BATRAC (Bilateral Arm Training with Rhythmic Auditory Cueing)
Number of subjects: 24
Study 18020847 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed message
Number of subjects: 121
Study 18020847 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 121
Study 15316334 — intervention group
Group type: EXPERIMENTAL
Intervention: peg-IFN alpha-2a 180 microg once weekly plus ribavirin 400 mg twice daily
Number of subjects: 859
Study 15316334 — intervention group
Group type: COMPARATOR
Intervention: IFN alpha-2a 3 million units three times weekly plus ribavirin 400 mg twice daily
Number of subjects: 859
Study 11254919 — intervention group
Group type: EXPERIMENTAL
Intervention: TRANS-diet (partially hydrogenated soybean oil)
Number of subjects: 9
Study 11254919 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFA-diet (high in polyunsaturated fatty acids)
Number of subjects: 9
Study 11254919 — intervention group
Group type: COMPARATOR
Intervention: PALM-diet (palm oil)
Number of subjects: 9
Study 8996463 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully adherent exercise group
Number of subjects: 105
Study 8996463 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially adherent exercise group
Number of subjects: 105
Study 8996463 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study 8287661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac transplant group
Number of subjects: 12
Study 8287661 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 3305990 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine needle aspiration of the prostate before prostatectomy
Number of subjects: 102
Study 31756173 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy (MIDP)
Number of subjects: 2921
Study 31756173 — intervention group
Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 2921
Study 30411130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:Yap laser combined with composite resin
Number of subjects: 70
Study 30411130 — intervention group
Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 70
Study 26759152 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age (73.3%)
Number of subjects: 326
Study 26759152 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe pain (64.0%)
Number of subjects: 326
Study 26759152 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe radiological OA (96.9%)
Number of subjects: 326
Study 24977974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal contraception
Number of subjects: 20
Study 24977974 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 22999700 — intervention group
Group type: EXPERIMENTAL
Intervention: Shang Ring circumcision
Number of subjects: 833
Study 22999700 — intervention group
Group type: COMPARATOR
Intervention: Conventional sleeve resection circumcision
Number of subjects: 833
Study 20435202 — intervention group
Group type: EXPERIMENTAL
Intervention: Core laboratory (CL) estimation of post-PCI TIMI flow grade
Number of subjects: 922
Study 20435202 — intervention group
Group type: COMPARATOR
Intervention: Local investigators (LI) estimation of TIMI flow grade
Number of subjects: 922
Study 20435202 — intervention group
Group type: COMPARATOR
Intervention: Pre-PCI TIMI flow grade assessment
Number of subjects: 922
Study 18664620 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral doses of pantoprazole (20 mg or 40 mg)
Number of subjects: 0
Study 18664620 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous doses of pantoprazole (0.8 mg/kg or 1.6 mg/kg)
Number of subjects: 0
Study 18664620 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of pantoprazole (oral and intravenous)
Number of subjects: 0
Study 16650135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 300 mg daily
Number of subjects: 29
Study 16650135 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 300 mg daily
Number of subjects: 29
Study 14675575 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta VBT
Number of subjects: 636
Study 14675575 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma VBT
Number of subjects: 636
Study 14675575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 636
Study 11016911 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg
Number of subjects: 81
Study 11016911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 9001830 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg suspension
Number of subjects: 3
Study 9001830 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg capsule (laboratory batch)
Number of subjects: 3
Study 9001830 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg capsule (production batch)
Number of subjects: 3
Study 1461795 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 0
Study 1461795 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 6143969 — intervention group
Group type: EXPERIMENTAL
Intervention: BM 13.177
Number of subjects: 0
Study 6143969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31613883 — intervention group
Group type: EXPERIMENTAL
Intervention: Community treatment using ready-to-use therapeutic food
Number of subjects: 2869
Study 29961295 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous plasma filtration group
Number of subjects: 86
Study 29961295 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment group
Number of subjects: 86
Study 27331783 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost high psychological fidelity simulation with debriefing
Number of subjects: 20
Study 27331783 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study 24552977 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 7.5 mg
Number of subjects: 1174
Study 24552977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1174
Study 20663779 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral screen (OS) application
Number of subjects: 56
Study 20663779 — intervention group
Group type: COMPARATOR
Intervention: Control group (small‐dimensioned air‐permeable end cap (EC))
Number of subjects: 56
Study 17978594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (2.5, 5, 10, 20, or 40 mg once daily)
Number of subjects: 300
Study 17978594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (10 mg and higher)
Number of subjects: 300
Study 17978594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 14534925 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of regular-release (RR) and sustained-release (SR) levodopa/benserazide
Number of subjects: 23
Study 11069460 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg daily for 48 weeks
Number of subjects: 212
Study 11069460 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 48 weeks
Number of subjects: 212
Study 9238408 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG criteria (Casale/Devereux, Cornell product, Cornell voltage, 12‐lead voltage product, sum of the 12‐lead, Rautaharju, Sokolow‐Lyon, Romhilt‐Estes point score)
Number of subjects: 0
Study 9238408 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo‐LVM index
Number of subjects: 0
Study 9238408 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG measurements combined with non‐ECG characteristics
Number of subjects: 0
Study 1595992 — intervention group
Group type: EXPERIMENTAL
Intervention: SK&F 104353 (800 micrograms inhaled)
Number of subjects: 18
Study 1595992 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (20 mg)
Number of subjects: 18
Study 1595992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6379136 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate administration of a three-dose course of intravenously administered indomethacin in addition to usual medical therapy (fluid restriction and use of diuretics or digitalis or both)
Number of subjects: 0
Study 6379136 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual medical therapy alone initially, with indomethacin as the first and surgery as the final backup measure
Number of subjects: 0
Study 6379136 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual medical therapy alone initially, with surgery alone as backup
Number of subjects: 0
Study 6379136 — intervention group
Group type: COMPARATOR
Intervention: Usual medical therapy with surgery as backup
Number of subjects: 0
Study 6379136 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin as part of initial treatment
Number of subjects: 0
Study 30376652 — intervention group
Group type: EXPERIMENTAL
Intervention: CSBI (schoolMAX)
Number of subjects: 103
Study 30376652 — intervention group
Group type: COMPARATOR
Intervention: SAU (services-as-usual)
Number of subjects: 103
Study 28356648 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise and joint mobilization (Group II)
Number of subjects: 18
Study 28356648 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercise only (Group I)
Number of subjects: 18
Study 25760553 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (probiotic)
Number of subjects: 75
Study 25760553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 23374677 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 0.5 mg
Number of subjects: 20
Study 23374677 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 2 mg
Number of subjects: 20
Study 23374677 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg
Number of subjects: 20
Study 23374677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 23374677 — intervention group
Group type: COMPARATOR
Intervention: Comparison with children from trial before fortification
Number of subjects: 20
Study 21185401 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 508
Study 21185401 — intervention group
Group type: COMPARATOR
Intervention: CRT OFF
Number of subjects: 508
Study 21185401 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON with reverse remodeling
Number of subjects: 508
Study 21185401 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON without reverse remodeling
Number of subjects: 508
Study 19928739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberous sclerosis patients
Number of subjects: 23
Study 19928739 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 23
Study 17244900 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine infused intra‐articular at 4 mL/hour for 72 hours
Number of subjects: 63
Study 17244900 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline infused intra‐articular at 4 mL/hour for 72 hours (placebo)
Number of subjects: 63
Study 17244900 — intervention group
Group type: COMPARATOR
Intervention: No intra‐articular infusion catheter (control)
Number of subjects: 63
Study 16702565 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural restriction (cervical collar and upright head position for 2 days)
Number of subjects: 119
Study 16702565 — intervention group
Group type: COMPARATOR
Intervention: No postural restriction
Number of subjects: 119
Study 16702565 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural restriction
Number of subjects: 119
Study 16702565 — intervention group
Group type: COMPARATOR
Intervention: Postural restriction vs No postural restriction
Number of subjects: 119
Study 10819474 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative SIRS(+) patients
Number of subjects: 40
Study 10819474 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative SIRS(+) patients with complications
Number of subjects: 40
Study 10819474 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative SIRS(+) patients lasting 3 days or longer
Number of subjects: 40
Study 10819474 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS(+) patients
Number of subjects: 40
Study 10819474 — intervention group
Group type: COMPARATOR
Intervention: SIRS(-) patients
Number of subjects: 40
Study 8797186 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline (NT) 75 mg daily for up to 7 weeks
Number of subjects: 38
Study 8797186 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline (NT)
Number of subjects: 38
Study 1640806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg)
Number of subjects: 11
Study 1640806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine HCl (1.25 and 1.9 mg/kg)
Number of subjects: 11
Study 1640806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) with Cocaine
Number of subjects: 11
Study 1640806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol with Cocaine
Number of subjects: 11
Study 1640806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaethylene
Number of subjects: 11
Study 1640806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lidocaine and mannitol)
Number of subjects: 11
Study 6151505 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (maximum 170 mg)
Number of subjects: 16
Study 6151505 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (maximum 187.5 mg)
Number of subjects: 16
Study 6151505 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (various doses: 10 mg, 17.5 mg, 45 mg)
Number of subjects: 16
Study 6151505 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (various doses: 37.5 mg, 187.5 mg)
Number of subjects: 16
Study 6151505 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled isoprenaline
Number of subjects: 16
Study 30902396 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA (2 bolus of 10mg/kg)
Number of subjects: 44
Study 30902396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 30211993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating-rotating electric toothbrush, stannous fluoride dentifrice, and dental floss
Number of subjects: 120
Study 30211993 — intervention group
Group type: COMPARATOR
Intervention: Regular manual toothbrush and anti-cavity sodium fluoride dentifrice
Number of subjects: 120
Study 26847307 — intervention group
Group type: EXPERIMENTAL
Intervention: CC depth of 6-7 cm (G 6-7)
Number of subjects: 62
Study 26847307 — intervention group
Group type: COMPARATOR
Intervention: CC depth of 5-6 cm (G 5-6)
Number of subjects: 62
Study 25533560 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple conjunctival resection
Number of subjects: 33
Study 25533560 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival resection and scleral fixation
Number of subjects: 33
Study 22040259 — intervention group
Group type: EXPERIMENTAL
Intervention: Funhaler
Number of subjects: 132
Study 22040259 — intervention group
Group type: COMPARATOR
Intervention: Aerochamber Plus
Number of subjects: 132
Study 20084363 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up
Number of subjects: 164
Study 20084363 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine follow-up and quarterly telephone contact
Number of subjects: 164
Study 20084363 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine follow-up and monthly telephone contact
Number of subjects: 164
Study 18773604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=1019)
Number of subjects: 2024
Study 18773604 — intervention group
Group type: COMPARATOR
Intervention: Usual Care group (n=1005)
Number of subjects: 2024
Study 15911037 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative treatment
Number of subjects: 30
Study 15911037 — intervention group
Group type: COMPARATOR
Intervention: Psychopharmacological therapy
Number of subjects: 30
Study 12790358 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro incubation of Tc-99m-HMPAO
Number of subjects: 19
Study 12790358 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of Tc-99m-HMPAO
Number of subjects: 19
Study 12790358 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of Tc-99m-HMPAO
Number of subjects: 19
Study 12790358 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc-99m-HMPAO adherence to mucus after inhalation
Number of subjects: 19
Study 10559508 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG CoA reductase inhibitor medication (statins)
Number of subjects: 45
Study 8907672 — intervention group
Group type: EXPERIMENTAL
Intervention: Luminol
Number of subjects: 47
Study 8907672 — intervention group
Group type: EXPERIMENTAL
Intervention: Lucigenin
Number of subjects: 47
Study 8907672 — intervention group
Group type: EXPERIMENTAL
Intervention: Phorbol 12-myristate 13-acetate
Number of subjects: 47
Study 8907672 — intervention group
Group type: COMPARATOR
Intervention: Centrifugation
Number of subjects: 47
Study 8907672 — intervention group
Group type: COMPARATOR
Intervention: Swim-up preparation
Number of subjects: 47
Study 1781468 — intervention group
Group type: EXPERIMENTAL
Intervention: Illumination level of 146 foot-candles
Number of subjects: 10888
Study 1781468 — intervention group
Group type: COMPARATOR
Intervention: Illumination level of 45 foot-candles
Number of subjects: 10888
Study 1781468 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prescription error rate
Number of subjects: 10888
Study 30284352 — intervention group
Group type: COMPARATOR
Intervention: MCT with RT
Number of subjects: 96
Study 30284352 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT with RT
Number of subjects: 96
Study 30284352 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 27629570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 20
Study 25953020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided regional anesthesia (US-RA)
Number of subjects: 60
Study 25953020 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 60
Study 24103080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal indices of adrenarche and gonadarche measured through saliva samples
Number of subjects: 1239
Study 24103080 — intervention group
Group type: EXPERIMENTAL
Intervention: Student, parent, and teacher questionnaires; anthropometric measurements
Number of subjects: 1239
Study 21102589 — intervention group
Group type: EXPERIMENTAL
Intervention: Figitumumab (F) at doses of 10 or 20 mg/kg (PCF10, PCF20)
Number of subjects: 110
Study 21102589 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin (PC)
Number of subjects: 110
Study 20379151 — intervention group
Group type: EXPERIMENTAL
Intervention: Taranabant 0.5 mg
Number of subjects: 784
Study 20379151 — intervention group
Group type: EXPERIMENTAL
Intervention: Taranabant 1 mg
Number of subjects: 784
Study 20379151 — intervention group
Group type: EXPERIMENTAL
Intervention: Taranabant 2 mg
Number of subjects: 784
Study 20379151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 784
Study 17169593 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 24
Study 17169593 — intervention group
Group type: COMPARATOR
Intervention: Control group of children with ADHD
Number of subjects: 24
Study 17169593 — intervention group
Group type: COMPARATOR
Intervention: Control group of children with dyslexia
Number of subjects: 24